Changes of copper level and cytochrome c oxidase activity in the macular mouse with age

The macular mouse is an animal model of Menkes disease. The neurological degeneration is caused by decreased cuproenzymes activity, such as cytochrome c oxidase (CCO), associated with copper deficiency in the brain. We investigated the age-related changes in copper concentration and CCO activity in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain & development (Tokyo. 1979) 1991-05, Vol.13 (3), p.184-186
Hauptverfasser: Meguro, Yuko, Kodama, Hiroko, Abe, Toshiaki, Kobayashi, Shigeichi, Kodama, Yukio, Nishimura, Masahiko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 186
container_issue 3
container_start_page 184
container_title Brain & development (Tokyo. 1979)
container_volume 13
creator Meguro, Yuko
Kodama, Hiroko
Abe, Toshiaki
Kobayashi, Shigeichi
Kodama, Yukio
Nishimura, Masahiko
description The macular mouse is an animal model of Menkes disease. The neurological degeneration is caused by decreased cuproenzymes activity, such as cytochrome c oxidase (CCO), associated with copper deficiency in the brain. We investigated the age-related changes in copper concentration and CCO activity in the brain of macular mice which were given a single injection of cupric chloride on postnatal day 7. The copper concentration in the brain of macular mice was always about 40% of that of the age-matched controls. However, the copper concentration of both macular and control mice increased with age gradually. The CCO activity in the brain of macular mice was significantly lower than that of controls at the age of 8 days. However the activity in macular mice increased with growth and reached a level equal to the controls at 180 days. These results suggest that the improvement of CCO activity in the brain of macular mice is due to the brain copper concentration which increased with age. Therefore, parenteral administration of copper is recommended especially during infancy in patients with Menkes disease.
doi_str_mv 10.1016/S0387-7604(12)80027-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72161836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0387760412800271</els_id><sourcerecordid>72161836</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-610cd468ecf34aef27c469da2b1467c37d36ce165b9d8f07871da189b8e273313</originalsourceid><addsrcrecordid>eNqFkE1vEzEQhi0EatPAT6jkQ4XoYcFjb2znVKGIfkiVOADiaDnj2cbV7jq1N4H8ezZN1B45zeF9ZubVw9g5iM8gQH_5IZQ1ldGi_gTy0gohTQVv2ASskZUBBW_Z5AU5ZWelPAohQII4YSegZ9oKM2G_FyvfP1DhqeGY1mvKvKUttdz3geNuSLjKqSOOPP2NwRfiHoe4jcOOx54PK-Kdx03rM-_SZkz_xGHF_QO9Z-8a3xb6cJxT9uv628_FbXX__eZu8fW-QmXnQ6VBYKi1JWxU7amRBms9D14uodYGlQlKI41tl_NgG2GsgeDBzpeWpFEK1JR9PNxd5_S0oTK4LhaktvU9jYWckaDBKj2CswOIOZWSqXHrHDufdw6E2wt1z0Ld3pYD6Z6Fuv2D8-ODzbKj8Lp1MDjmF8fcF_Rtk32Psbxgs1oqqfbY1QGjUcY2UnYFI_VIIWbCwYUU_1PkH8XskYY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72161836</pqid></control><display><type>article</type><title>Changes of copper level and cytochrome c oxidase activity in the macular mouse with age</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Meguro, Yuko ; Kodama, Hiroko ; Abe, Toshiaki ; Kobayashi, Shigeichi ; Kodama, Yukio ; Nishimura, Masahiko</creator><creatorcontrib>Meguro, Yuko ; Kodama, Hiroko ; Abe, Toshiaki ; Kobayashi, Shigeichi ; Kodama, Yukio ; Nishimura, Masahiko</creatorcontrib><description>The macular mouse is an animal model of Menkes disease. The neurological degeneration is caused by decreased cuproenzymes activity, such as cytochrome c oxidase (CCO), associated with copper deficiency in the brain. We investigated the age-related changes in copper concentration and CCO activity in the brain of macular mice which were given a single injection of cupric chloride on postnatal day 7. The copper concentration in the brain of macular mice was always about 40% of that of the age-matched controls. However, the copper concentration of both macular and control mice increased with age gradually. The CCO activity in the brain of macular mice was significantly lower than that of controls at the age of 8 days. However the activity in macular mice increased with growth and reached a level equal to the controls at 180 days. These results suggest that the improvement of CCO activity in the brain of macular mice is due to the brain copper concentration which increased with age. Therefore, parenteral administration of copper is recommended especially during infancy in patients with Menkes disease.</description><identifier>ISSN: 0387-7604</identifier><identifier>EISSN: 1872-7131</identifier><identifier>DOI: 10.1016/S0387-7604(12)80027-1</identifier><identifier>PMID: 1656807</identifier><identifier>CODEN: NTHAA7</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Aging - metabolism ; Animals ; Biological and medical sciences ; brain ; Brain - enzymology ; Copper - blood ; copper concentration ; cytochrome c oxidase ; Disease Models, Animal ; Electron Transport Complex IV - metabolism ; macular mice ; Male ; Medical sciences ; Menkes disease ; Menkes Kinky Hair Syndrome - enzymology ; Menkes Kinky Hair Syndrome - metabolism ; Metabolic diseases ; Mice ; Mice, Neurologic Mutants</subject><ispartof>Brain &amp; development (Tokyo. 1979), 1991-05, Vol.13 (3), p.184-186</ispartof><rights>1991</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-610cd468ecf34aef27c469da2b1467c37d36ce165b9d8f07871da189b8e273313</citedby><cites>FETCH-LOGICAL-c389t-610cd468ecf34aef27c469da2b1467c37d36ce165b9d8f07871da189b8e273313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0387-7604(12)80027-1$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5423237$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1656807$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meguro, Yuko</creatorcontrib><creatorcontrib>Kodama, Hiroko</creatorcontrib><creatorcontrib>Abe, Toshiaki</creatorcontrib><creatorcontrib>Kobayashi, Shigeichi</creatorcontrib><creatorcontrib>Kodama, Yukio</creatorcontrib><creatorcontrib>Nishimura, Masahiko</creatorcontrib><title>Changes of copper level and cytochrome c oxidase activity in the macular mouse with age</title><title>Brain &amp; development (Tokyo. 1979)</title><addtitle>Brain Dev</addtitle><description>The macular mouse is an animal model of Menkes disease. The neurological degeneration is caused by decreased cuproenzymes activity, such as cytochrome c oxidase (CCO), associated with copper deficiency in the brain. We investigated the age-related changes in copper concentration and CCO activity in the brain of macular mice which were given a single injection of cupric chloride on postnatal day 7. The copper concentration in the brain of macular mice was always about 40% of that of the age-matched controls. However, the copper concentration of both macular and control mice increased with age gradually. The CCO activity in the brain of macular mice was significantly lower than that of controls at the age of 8 days. However the activity in macular mice increased with growth and reached a level equal to the controls at 180 days. These results suggest that the improvement of CCO activity in the brain of macular mice is due to the brain copper concentration which increased with age. Therefore, parenteral administration of copper is recommended especially during infancy in patients with Menkes disease.</description><subject>Aging - metabolism</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>brain</subject><subject>Brain - enzymology</subject><subject>Copper - blood</subject><subject>copper concentration</subject><subject>cytochrome c oxidase</subject><subject>Disease Models, Animal</subject><subject>Electron Transport Complex IV - metabolism</subject><subject>macular mice</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Menkes disease</subject><subject>Menkes Kinky Hair Syndrome - enzymology</subject><subject>Menkes Kinky Hair Syndrome - metabolism</subject><subject>Metabolic diseases</subject><subject>Mice</subject><subject>Mice, Neurologic Mutants</subject><issn>0387-7604</issn><issn>1872-7131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1vEzEQhi0EatPAT6jkQ4XoYcFjb2znVKGIfkiVOADiaDnj2cbV7jq1N4H8ezZN1B45zeF9ZubVw9g5iM8gQH_5IZQ1ldGi_gTy0gohTQVv2ASskZUBBW_Z5AU5ZWelPAohQII4YSegZ9oKM2G_FyvfP1DhqeGY1mvKvKUttdz3geNuSLjKqSOOPP2NwRfiHoe4jcOOx54PK-Kdx03rM-_SZkz_xGHF_QO9Z-8a3xb6cJxT9uv628_FbXX__eZu8fW-QmXnQ6VBYKi1JWxU7amRBms9D14uodYGlQlKI41tl_NgG2GsgeDBzpeWpFEK1JR9PNxd5_S0oTK4LhaktvU9jYWckaDBKj2CswOIOZWSqXHrHDufdw6E2wt1z0Ld3pYD6Z6Fuv2D8-ODzbKj8Lp1MDjmF8fcF_Rtk32Psbxgs1oqqfbY1QGjUcY2UnYFI_VIIWbCwYUU_1PkH8XskYY</recordid><startdate>199105</startdate><enddate>199105</enddate><creator>Meguro, Yuko</creator><creator>Kodama, Hiroko</creator><creator>Abe, Toshiaki</creator><creator>Kobayashi, Shigeichi</creator><creator>Kodama, Yukio</creator><creator>Nishimura, Masahiko</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>199105</creationdate><title>Changes of copper level and cytochrome c oxidase activity in the macular mouse with age</title><author>Meguro, Yuko ; Kodama, Hiroko ; Abe, Toshiaki ; Kobayashi, Shigeichi ; Kodama, Yukio ; Nishimura, Masahiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-610cd468ecf34aef27c469da2b1467c37d36ce165b9d8f07871da189b8e273313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Aging - metabolism</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>brain</topic><topic>Brain - enzymology</topic><topic>Copper - blood</topic><topic>copper concentration</topic><topic>cytochrome c oxidase</topic><topic>Disease Models, Animal</topic><topic>Electron Transport Complex IV - metabolism</topic><topic>macular mice</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Menkes disease</topic><topic>Menkes Kinky Hair Syndrome - enzymology</topic><topic>Menkes Kinky Hair Syndrome - metabolism</topic><topic>Metabolic diseases</topic><topic>Mice</topic><topic>Mice, Neurologic Mutants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meguro, Yuko</creatorcontrib><creatorcontrib>Kodama, Hiroko</creatorcontrib><creatorcontrib>Abe, Toshiaki</creatorcontrib><creatorcontrib>Kobayashi, Shigeichi</creatorcontrib><creatorcontrib>Kodama, Yukio</creatorcontrib><creatorcontrib>Nishimura, Masahiko</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>Brain &amp; development (Tokyo. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meguro, Yuko</au><au>Kodama, Hiroko</au><au>Abe, Toshiaki</au><au>Kobayashi, Shigeichi</au><au>Kodama, Yukio</au><au>Nishimura, Masahiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes of copper level and cytochrome c oxidase activity in the macular mouse with age</atitle><jtitle>Brain &amp; development (Tokyo. 1979)</jtitle><addtitle>Brain Dev</addtitle><date>1991-05</date><risdate>1991</risdate><volume>13</volume><issue>3</issue><spage>184</spage><epage>186</epage><pages>184-186</pages><issn>0387-7604</issn><eissn>1872-7131</eissn><coden>NTHAA7</coden><abstract>The macular mouse is an animal model of Menkes disease. The neurological degeneration is caused by decreased cuproenzymes activity, such as cytochrome c oxidase (CCO), associated with copper deficiency in the brain. We investigated the age-related changes in copper concentration and CCO activity in the brain of macular mice which were given a single injection of cupric chloride on postnatal day 7. The copper concentration in the brain of macular mice was always about 40% of that of the age-matched controls. However, the copper concentration of both macular and control mice increased with age gradually. The CCO activity in the brain of macular mice was significantly lower than that of controls at the age of 8 days. However the activity in macular mice increased with growth and reached a level equal to the controls at 180 days. These results suggest that the improvement of CCO activity in the brain of macular mice is due to the brain copper concentration which increased with age. Therefore, parenteral administration of copper is recommended especially during infancy in patients with Menkes disease.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>1656807</pmid><doi>10.1016/S0387-7604(12)80027-1</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0387-7604
ispartof Brain & development (Tokyo. 1979), 1991-05, Vol.13 (3), p.184-186
issn 0387-7604
1872-7131
language eng
recordid cdi_proquest_miscellaneous_72161836
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Aging - metabolism
Animals
Biological and medical sciences
brain
Brain - enzymology
Copper - blood
copper concentration
cytochrome c oxidase
Disease Models, Animal
Electron Transport Complex IV - metabolism
macular mice
Male
Medical sciences
Menkes disease
Menkes Kinky Hair Syndrome - enzymology
Menkes Kinky Hair Syndrome - metabolism
Metabolic diseases
Mice
Mice, Neurologic Mutants
title Changes of copper level and cytochrome c oxidase activity in the macular mouse with age
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T18%3A13%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20of%20copper%20level%20and%20cytochrome%20c%20oxidase%20activity%20in%20the%20macular%20mouse%20with%20age&rft.jtitle=Brain%20&%20development%20(Tokyo.%201979)&rft.au=Meguro,%20Yuko&rft.date=1991-05&rft.volume=13&rft.issue=3&rft.spage=184&rft.epage=186&rft.pages=184-186&rft.issn=0387-7604&rft.eissn=1872-7131&rft.coden=NTHAA7&rft_id=info:doi/10.1016/S0387-7604(12)80027-1&rft_dat=%3Cproquest_cross%3E72161836%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72161836&rft_id=info:pmid/1656807&rft_els_id=S0387760412800271&rfr_iscdi=true